V

Verastem Oncology

73 employees

Verastem is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Pharmaceutical
cancer
CLL
biotechnology
Biopharma
Lymphoma
T Cell Lymphoma
clinical trials
Oncology
NHL
pharmaceutical
hematology
blood cancer
cancer research

Date founded

2010

Funding rounds raised

Total raised

$32M

from 16 investors over 16 rounds

V

Verastem Oncology raised $25M on March 28, 2022

Investors: Oxford Finance LLC

V

Verastem Oncology raised $25M on March 23, 2017

Investors: Hercules Capital, Inc.

V

Verastem Oncology raised $20M on November 11, 2011

Investors: Cardinal Partners (CP), Bessemer Venture Partners, MPM Capital and Longwood Fund

V

Verastem Oncology raised $32M on July 14, 2011

Investors: Advanced Technology Ventures, Cardinal Partners (CP), Astellas Venture Capital L.L.C., Bessemer Venture Partners, MPM Capital and Longwood Fund

V

Verastem Oncology raised $16M on November 16, 2010

Investors: Cardinal Partners (CP), Longwood Fund, MPM Capital and Bessemer Venture Partners

FAQ